Published in Transfus Med Rev on April 01, 2008
Molecular genetics and clinical applications for RH. Transfus Apher Sci (2011) 1.57
The molecular genetics of blood group polymorphism. Hum Genet (2009) 1.50
The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus (2010) 1.03
Transfusion in the age of molecular diagnostics. Hematology Am Soc Hematol Educ Program (2009) 1.03
An easy and efficient strategy for KEL genotyping in a multiethnic population. Rev Bras Hematol Hemoter (2013) 0.92
Microarray Beads for Identifying Blood Group Single Nucleotide Polymorphisms. Transfus Med Hemother (2009) 0.92
The Lombardy Rare Donor Programme. Blood Transfus (2013) 0.91
Applications and Experience with PCR-Based Assays to Predict Blood Group Antigens. Transfus Med Hemother (2009) 0.88
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012. Blood Transfus (2013) 0.84
Genotyping patients' and donors' blood groups for efficient blood therapy. Blood Transfus (2012) 0.82
Comment on "Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand". Blood Transfus (2014) 0.82
A rewarding fresh look at routine blood group data. Blood Transfus (2008) 0.82
Scianna: the lucky 13th blood group system. Immunohematology (2011) 0.77
External quality assessment in molecular immunohematology: the INSTAND proficiency test program. Transfusion (2013) 0.76
A model for integrating molecular-based testing in transfusion services. Blood Transfus (2015) 0.75
A Microsphere-Based Suspension Array for Blood Group Molecular Typing: An Update. Transfus Med Hemother (2010) 0.75
Clinical Utility of Genotyping Human Erythrocyte Antigens. Lab Med (2016) 0.75
Duffy and kidd genotyping facilitates pretransfusion testing in patients undergoing long-term transfusion therapy. Turk J Haematol (2014) 0.75
Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol (2017) 0.75
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2010) 3.47
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher (2013) 2.97
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood (2003) 1.82
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma (2009) 1.56
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion (2004) 1.43
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion (2012) 1.38
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2007) 1.38
Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses. Infect Immun (2004) 1.32
Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. Proc Natl Acad Sci U S A (2005) 1.30
Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol (2002) 1.30
Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr (2011) 1.23
Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr (2010) 1.10
Teaching laboratory medicine to medical students: implementation and evaluation. Arch Pathol Lab Med (2012) 1.00
Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest (2016) 0.97
Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma (2011) 0.95
A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg (2011) 0.94
Early predictors of massive transfusion in patients sustaining torso gunshot wounds in a civilian level I trauma center. J Trauma (2010) 0.93
Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion (2011) 0.92
Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy. Pharmacotherapy (2012) 0.88
The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg (2011) 0.88
Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. Am Surg (2012) 0.88
Massive transfusion: blood component ratios. Curr Opin Hematol (2013) 0.87
Blood donations motivators and barriers: a descriptive study of African American and white voters. Transfus Apher Sci (2012) 0.86
Base deficit as a marker of survival after traumatic injury: consistent across changing patient populations and resuscitation paradigms. J Trauma Acute Care Surg (2012) 0.85
McLeod phenotype without the McLeod syndrome. Transfusion (2007) 0.85
Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion (2011) 0.84
The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher (2007) 0.83
Contribution of attitudinal factors to blood donation in African American church attendees. Transfusion (2010) 0.83
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
Development of common metrics for donation attitude, subjective norm, perceived behavioral control, and intention for the blood donation context. Transfusion (2013) 0.82
The blood donor identity survey: a multidimensional measure of blood donor motivations. Transfusion (2014) 0.81
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion (2013) 0.81
The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion (2014) 0.81
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Am J Hematol (2012) 0.81
Heparin-induced thrombocytopenia and cardiac surgery. Curr Opin Anaesthesiol (2010) 0.80
Initiation and regulation of complement during hemolytic transfusion reactions. Clin Dev Immunol (2012) 0.80
Emerging Infections and Blood Safety in the 21st Century. Ann Intern Med (2016) 0.79
The value of area-based analyses of donation patterns for recruitment strategies. Transfusion (2014) 0.78
Development of a fast and simple liquid chromatography-tandem mass spectrometry method for the quantitation of argatroban in patient plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.78
Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. Blood (2014) 0.78
Is there transfusion-related acute renal injury? Anesthesiology (2010) 0.78
Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City. Transfusion (2014) 0.78
West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic. Transfusion (2012) 0.77
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors? Transfusion (2011) 0.76
Plasma exchange in pancreatitis due to hypertriglyceridemia. Transfusion (2009) 0.75
Let technology do the work: Improving prediction of massive transfusion with the aid of a smartphone application. J Trauma Acute Care Surg (2013) 0.75
Measuring the processes of change for increasing blood donation in black adults. Transfusion (2012) 0.75
Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation. Arch Pathol Lab Med (2017) 0.75
Case report and literature review: transient Inab phenotype and an agglutinating anti-IFC in a patient with a gastrointestinal problem. Transfusion (2006) 0.75
The top clinical trial opportunities in therapeutic apheresis and neurology. J Clin Apher (2014) 0.75
Current patterns of use in therapeutic apheresis: a metropolitan center experience. Transfusion (2014) 0.75
The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfus Apher Sci (2013) 0.75
Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease. Arch Pathol Lab Med (2016) 0.75
Disparate hemoglobin results. Clin Chem (2013) 0.75
Cardiovascular disease risk assessment and prevention in blood donors. Transfusion (2012) 0.75